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The extent to which a melanocyte-stimulating hormone 
(MSH) is a true in vivo regulator of melanogenesis in mice is 
unknown. The objective of this study was to determine if 
MSH-induced eumelanogenesis in hairbulb melanocytes of 
yellow (AY /a) mice mimics the natural program of eumelan-
ogenesis occurring in genetically black (a/a) hairbulb mela-
nocytes. We conducted quantitative transmission electron 
microscopy on melanosome differentiation within MSH-
treated regenerating 9-d hairbulbs of AY ja and aja mice. Re-
su lts of exogenous a-MSH injections (5 d at 0.15 mM MSH) 
showed that the striking visual darkening of hair was accom-
panied by an incomplete transformation of phaeo- to eume-
lanogenesis. Ontogenetic data on developmental stages I- IV 
of 3678 melanosomes based on geometric considerations 
(length, width, shape, and area) showed that MSH did not 
W hen treated with MSH, cu ltured melanoma cells undergo a predictable cascade of events [1], including binding ofMSH to melanocyte receptors, internalization of MSH, rapid rise in cytoplasmic cyclic AMP concentration, an 
increase in tyrosinase activity, and accelerated melanin synthesis. 
T his MSH-induced enhancement of melano genesis is most likely 
due to both new tyrosinase synthesis [2,3] as well as activation , by 
any one of a number of mec hanisms, of previously synthesized but 
inac tive tyrosinase molecules [4- 6]. . . 
Melanogenesis within murine hairbulb melanocytes 1s also stimu-
lated by MSH [7 -12]. MSH induces a switch in the program of 
lethal ye ll ow mouse (AY /a) melanin synthesis from yellow tq black 
(7] . The MSH-induced switch from phaeo- co eumelanogenesis 
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induce a complete transformation from spherical phaeome-
lanosomes to elliptical eumelanosomes. Also, observations on 
the number of vesiculoglobular bodies and matrix organiza-
tion revealed that MSH-treated AY /a melanosomes retained 
distinct features of phaeomelanogenesis even after 5 d of 
MSH treatment. Thus, MSH induced a partial but incom-
plete pattern of eumelanogenesis in regenerating hairbulb 
melanocytes of AY /a mice. The continued investigation of 
the dynamics of melanin synthesis in MSH-induced AY /a 
mice melanocytes possessing "mosaic" melanosomes could 
be productive in understanding fundamental relationships 
between tyrosinase activity, matrix function, matrix struc-
ture, and regulation of melanin (phaeo- and/or eumelanin) 
synthesis. J Invest Derrnatol96:78-84, 1991 
occurred in hairbulb melanocytes of cultured mouse skin explams 
within 12 h [8,23). Hairbulb melanocytes ofC3H-He Avy j Avy mice 
were responsive to MSH during puberty but refractory to MSH as 
adults; because plasma a-MSH levels were virtually identical in 
both pubertal and adult AvY-homozygotes, MSH receptor dynamics 
may differ with age [13]. In the presence of theophylline (2 mM), 
dbcAMP (2 mM), and a-MSH (1.0 ug/ml), explanted AY ja hair-
bulbs underwent the yellow-to-black transformation; HPLC analy-
ses of melanin in the switched-over hairbulbs verified enhanced 
eumelanin (PTCA), as wel l as phaeomelanin (AHP) synthesis (1 0]. 
The objective of this study was to determine the extent to which 
a~MSH- induced eumelanogenesis in regenerating follicular mela-
nocytes of adult lethal yellow mice (Ar /a) actuall y mimics the natu-
ral program of eumelanogenesis that occurs in congenic nonagouti 
black (a/a) hairbulb melanocytes. In particular, we used transmis-
sion electron microscopy to compare melanosome ontogeny in 
MSH-treated aja with MSH-treated AY Ja. By using con genic 
C57BL/6J-a/a and AY /a mice, differences in ontogenetic patterns 
between these two genotypes cou ld be attributed to the action (or 
nonaction) of AY. 
MATERIALS AND METHODS 
' 
Dorsa of 60-80-day-old C57BL/6J-AY/a and -a/a anesthetized 
mice (The J ackson Laboratory , Bar Harbor, ME) were plucked. At 
16:00 on days 4-8 of regeneration, skins of dorsa were injected 
with a-MSH (Sigma-M4135) at a dose of 25.0 Jlg MSH/0.1 ml 
(0.15 rt_~) . Dorsa harvested at 08:00 on day 9 were prepared for 
transmiSSIOn electron microscopy [14). We then conducted quanti-
tative electron microscopy scoring for: (1) maturation stages I, II, 
Ill, or IV using established staging criteria [15); (2) length (nm); (3) 
width (nm); (4) matrix condition with 1 =no matrix components, 
2 = unorganized matrix components, 3 = both unorganized and 
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Figure 1. A, section through the Golgi zone of an MSH-treated aja mela-
nocyte. Note melanosomes in various stages of differentiation including 
stage II (II, left center) , stage Ill (lll, lower left), and stage IV (IV, cwter), and 
numerous coated vesicles (arrows). Ordered lon gitudinal matrix fibers arc 
apparent within the elliptical stage II melanosome. Coated vesicles diame-
ters measure 50 - 100 nm. Electron-dense coated vesicle coat components 
measure 11 - 18 nm. Magnification X 33,000. Bar, 500 nm; B, section 
through the Golgi zone of an MSH-trea ted lethal yellow (Ar fa) melanocyte. 
Stage III melanosomes contain unordered fibrillar components (II, botto111 left 
center, botto111 right) . Discrete centers of melanization are apparent with in the 
stage II melanosomes (III, top left) and measure 10 - 32 nm. Magnification, 
X 18,600. Bar, 500 nm. 
o rganized matrix components , and 4 = organized matri x compo-
nents only; (5) vesiculoglobular body (VG) score with 1 = 
complete absence of any vesicles (40 nm) with in melanosomes, 
2 =one to three vesicl es (40 nm) within melanosomes, and 3 = 
greater than three 40-nm vesicles within melanosomes. Length and 
w idth data were used to determine melanosome area by the formula 
A = pi X r2 where r = (1/2 + w /2)/2. Len gth-to-width ratios 
were calcu lated to provide an expression of melanosome shape; a 
ratio of 1.0 would describe a sphere, whereas ratios greater than 1.0 
would tend to be increasingly elliptical in shape. 
Continuous variables (l ength, width, ratio of length-to-width , 
and area) were statistically compared using an analysis of variance. 
Discontinuous variables were compared by the C hi-square statistic. 
Differences were considered to be signific;:lnt at the P < 0.05 level 
of probabi lity. 
RESULTS 
Qualitative Data Electronmicrographs of melanosome differ-
entiation in MSH-treated aja mice revealed patterns of classical 
eumelanogenesis (Fig 1A). Stage I multivesiculate premelanosomes 
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elongate to produce a matrix dominated by longitudinally-oriented, 
parallel, and organized fil aments (stage II melanosome-II, left 
center); upon melanization, thin matrix filaments thicken to form 
melanofilaments (stage III melanosome-III, lower a11d top left). In 
contrast, the program of phaeomelanosome differentiation in AY f a 
genotypes was profound ly affected by MSH. 
Melanosomes of MSH-treated AY fa mice possessed a hybrid ma-
trix which contained elements of both ph a eo- and eumelanosomes 
(Figs 1B, 2). Some mosaic matrices possessed well-defined longitu-
dinally-disposed primary melanofilaments characteristic of eumel-
anosomes plus numerous vesiculoglobular-like bodies sometimes 
associated with primary melanofilaments (Fig 2D, E, G) or in dis-
crete areas randoml y distributed within matrices (Fig 2A, B, F). 
Although not surrounded by a visible melanosomal membrane and 
therefore potentially granular endoplasmic reticulum, the string of 
electron-dense particles (Fig 2E, right center) strongly resembles fil a-
mentous components and vesiculoglobular-like bodies of stage II 
melanosomes. MSH-treated melanocytes possessed melanosomes 
that invariably retained a highly characteristic matrix coalescence 
reminiscent of classical vesiculog lobular body coalescence within 
phaeomelanosomes (15-18) . This clumping phenomenon (Fig 1B; 
2B, C) was highly diagnostic of MSH-treated AY fa melanocytes. In 
contrast, MSH-treated aja melanosomes exhibited distinct matrix 
differentiation patterns characteristic of filament elaboration that 
occurs during class ical eumelanogenesis (17); aja melanosomes did 
not possess coalescing matrices. To obtain numerical data on effects 
of MSH , we ana lyzed melanosomes for a number of quantitative 
parameters. 
Quantitative Data A total of 3678 melanosomes were scored, 
1837 for a/a and 1841 forAY fa. T able I, row 5 displays means of all 
developmental stages combined for each genotype; statistically sig-
nificant genotype differences occurred in length, width, and area 
between a-MSH- treated lethal yellow (AY /a) and nonagouti black 
(a/ a) genotypes. To determine the developmental origins of the 
differences, we examined each of these parameters during each stage 
of melanosome differentiation (Table I, rows 1-4; Fig 3). After 
staging each melanosome according to established maturation cri-
teria [15), we measured four independent melanosomal variables 
including length, width, matrix score, and vesiculoglobular body 
score. Length and width data were then used to determine length-
to-width ratios and melanosomal areas . 
With respect to length (Table I, Fig 3A), both a/a and AY fa 
genotypes generall y increased in length over the four developmen-
tal stages . Significant differences occurred at stages I, II, and IV, 
suggesting the MSH did not completely transform the lengths of 
AY fa melanosomes to those of aja. To determine consistent width 
measurements, we bisected the length measurement, drew a line 
perpendicular to the length, and recorded that perpendicular dis-
tance as width. Widths of MSH-treated a/a and AY fa melanosomes 
generall y exhibited increases over their ontogeny (Table I, Fig 3B); 
statistically significant differences occurred in stages I, III, and IV. 
Lengths and widths of a/a melanosomes exceeded those of AY fa 
melanosomes at all developmental stages except Stage III. 
Melanosomal shape is another cl ass ic characteristic of phaeo-
melanosome~ (sphe~1cal) and eumelanosomes (elliptical (18) . 
Length-to-width rat1os prov1de a means to estimate melanosomal 
shape. A ratio of 1.0 describes a round two-dimensional profile on 
the electronmicrograph; given sufficient numbers of such profiles, a 
ratio of 1.0 describes a three-dimensional sphere. In contrast, a 
length-to-width ratio of greater than 1.0 describes elliptically-
shaped melanosomes. Upon comparing length-to-width ratios of 
MSH-treated a/a to AY /a melanosomes (Table I, Fig 3C), significant 
differences occurred at developmental stages II and III. These data 
suggest a significant plasticity in the shape of aja melanosomes not 
found in those of AY fa. Melanosomal areas of both genotypes were 
compared during differentiation (Table I, Fig 3D). Overall, both 
genotypes underwent an approximate twofold increase in area dur-
ing maturation. However, significant differences occurred at devel-
opmental stages I, III , and IV. Stage III was unique, because it was 
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Figure 2. Mclanosomes of MSH-treated AY /a rnelanocytes. A, T wo stage III melanosornes (eel/fer top a11d botto111) displaying 12- 15-nm width filamen ts (arrows) and 40-nm -diameter vesiculoglobula r body components. Magnification X44,000 . Bar, 200 nm; B, four stage III melanosomes exhibiting typical 
"clumping" patterns of melanization especially in the bottom, highl y melanized melanosome. Filamentous components measuring 11 - 14 nm in width are 
also present (arrows). Magn ifica tion X42,750. Bar, 200 nm; C, Stage II melanosome (center) contammg a number of ves iculoglobular bodies measuring 30-60 
nm in diamete r. Melanosome in the upper right displays a typ ical "clumping" pattern of melanizatio n seen onl y in MSH-trea ted AY /a melanocytes not in 
MSH-treated a/a pigment ce ll s. Magn ification X36,000. Bar, 200 nm; D, Mosaic stage III mclanosomes containing both longitudinally ori en ted matrix 
fi laments and vesicul oglobular-like bodies (38 - 41 nm in diameter) linearl y arranged along the length of the matrix fil aments (arrows). M agnification 
X45,900. Bar, 200 nm; E Mosaic stage III melanosome showing primary long itudinal fiber orientation and linear arrangement of vesiculoglobular-like bodie (arrows) . N ote fil amentous components o f stage II melanosomes (right cwter). Magnifica tion X45,000. Bar, 200 nm; F, two stage III mosa ic melanosomes 
containing a primary fil amentous component measuring approximately 22 nm in width (arrow) and centers ofYG body coalescence . Melanogenes is appears to 
occur both on or along the matri x fibers and in peripheral areas. Magnifica tion X40,500. Bar, 200 nm ; G , Stage Ill mosaic melanosomc containing both ordered 
lo ngitudinally disposed pr imary fibers plus linea rl y arranged ves iculoglobular-like components, which measure 23-42 nm in diameter. Magnification 
X38,700. Bar, 200 nm. 
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Table I. Effect of the Lethal Yellow Allele (Ar) on Length, Width, Ratio , and Area of Melanosomes Following MSH Treatment 
Developmental 
a/a 
Stage' N Numbcrb Length' WidthJ 
I 239 393 298 
II 120 458 255 
III 342 475 324 
IV 1136 567 
Grand meansR 1837 520 
Control means!. [22] 864 515 
• Based on staging criteria of Jim bow and Takeuchi [15] . 
• Number of mclanosomcs scored for eac h developmental stage. 
' Mean length in nm. 
J Mean width in nm. 
~ Racio of mea n length to mean width . 
423 
377 
364 
f Area in nm2 X 1 0' . A= nr2, whe re r = (length/2 + width/ 2)/ 2. 
1 Means of all four developmental stages co mbined. 
h Measurements o n untreated neo natal hairbu lb mclanosomcs [22). 
; Genotypes were significantl y differe nt (p < 0.05) . 
Ratio' 
1.35 
1.86 
1.52 
1.36 
1.42 
1.53 
the onl y stage in which AY /a melanosomes possessed greater areas 
than those of a/a mice . 
Because phaeomelanosomes of AY /a mice and eumelanosomes of 
a/a mice exhibit uni9.ue patterns of structu.ral components withi.n 
their matnces (1 6, 17j, assess ment of matnces fol lowmg MSH IS 
critical to our understanding of the MSH-induced yellow-to-black 
transformation. Data presented in Table II and Fig 3E show the 
frequency of four different matrix configurations in both MSH-
treated genotypes. An overall C hi-square analysis revealed signifi-
cant ge notype differences; the most striking differences occurred at 
frequency scores of 1 (unorganized components) and 4 (organized 
components only). Unexpected ly, in none of the total of 1841 
MSH-treated AY /a melanosomes did we encounter the kind of eu-
melanosome- like matrix organization previously reported [7), Figs. 
13 -17), i.e., longitudinally arranged parall el filamentous com-
plexes showing typica l eumelanosome cross- linking. Instead, we 
found that on ly 27.0% (290 of 1075) ofMSH-treated AY /a melano-
somes rossessed an organized matrix compared to 55.6% (390 of 
702) o MSH-treated a/a contro ls (Table II). 
The number of 40-nm vesiculoglobular bodies (VG) within 
melanosomal matrices is also indicative of a/a or AY /a genotypes 
(15,1 6). Present data (Tab le II , Fig 3F) show significant frequency 
differences in VG scores between ge notypes; these data suggest that 
MS H did not cause a complete transformation from phaeo- to eu-
melanoge nesis with respect to the number of VG bodies within 
melanosomes. 
DISCUSSION 
The rel ationship between the melanosomal matrix, tyrosinase func-
tion, and the type of melanin synth esized (eu- and/or phaeomel-
an in) is of fundamental importance to melanogenesis. Also signifi-
cant are the physica l and/or biochemical bases of those agouti locus 
ge ne products that " throw the agouti switch. " In mice treated with 
MSH , the highly visible yellow-to-black transformation within 
hairbulb pigment cells verifies that MSH has " thrown" the switch. 
In addition to MSH, cAMP, dbcAMP, and theophylline can also 
induce eumelanin synthesis in Ar /a hairbulbs in vitro [8 ,10, 12). 
Based on these and other observations, Takeuchi and coworkers 
(24,25) postulated that gene products of the agouti locus may 
" . .. interact with a-MSH-cAMP system at the a -MSH recep-
tor." Although this is an attractive hypothesis, we don't know 
whether this exogenous MSH-induced switch is a true in vivo 
event, or how this and related events may be regulated by or related 
to the agouti locus. To address these issues, one can compare both 
functional phenomena such as tyros inase ac tivities (9, 11 - 13) and 
structural data such as melanosome differentiation in MSH-treated 
Genotype 
Ar/a 
Area/ N Number Length W idth Ratio Area 
9.4 171 3501 2541 1.42 7.2' 
10.0 100 3861 270 1.461 8.4 
12.5 804 487 3631 1.401 14.11 
19.2 766 4701 3631 1.34 13.6' 
16.1 1841 4621 3481 1.38 12.91 
15.2 337 5281 4061 1.331 17.21 
AY/a and MSH-treated aja (control) mice [1 9,20]. Data presented 
here deal with the morphologic comparison of melanosome on-
togeny using methods of quantitative electronmicroscopy. To ob-
tai n accurate quantitative data on melanosome differentiation, we 
attempted to minimize potential sources of error (sampling errors, 
errors in measuring geometric parameters of melanosomes on mi-
crographs, interpretations of developmental stage, magnification 
fluctuations of the TEM itself, enlargement errors, and others) 
when conducting quantitative electronmicroscopy. Although we 
exercised great care in each of these face ts (e.g., TEM magnifica-
tions were calibrated before and after each session), data from quan-
titative electronmicroscopic observations represent small samples 
from large populations and are therefore inherently problematic. 
Nonetheless, randomized data on 3678 total melanosomes (1 837 
a/a and 1841 AY /a) should represent a sample of sufficient size to 
make valid interpretati ons. 
Our rationale for this study was the fo llowing: if th e patterns of 
melanosome ontogeny of MSH-treated AY /a were identical to those 
of MSH-treated a/a mice, we could then conclude that MSH or 
compounds having MSH-like properties are capable of inducing a 
morphologicall y normal eumelanogenesis response in mice. Accord-
ingly, MSH or MSH-like molecu les may. play a true in vivo role in 
the regulation of melanogenesis within murine hairbulb melano-
cytes and may act in concert with other factors to regulate the agouti 
switch as previously suggested [1] . If, on the other hand, patterns of 
melanosome ontogeny differ between MSH-treated AY /a and aja 
mice, the likelihood that MSH is a true in vivo regulator of melano-
genesis may be decreased. However, it is also possible that the Ay 
mutation cause such profound lesions (major pertu rbations of 
melanogenesis) that a-MSH , the normal in vivo regulator of the 
agouti switch, cannot overcome these deleterious changes, i.e, com-
pletely restore the agouti switch. Finally, predictable and consistent 
differences ~n melanosome ontogeny between MSH-treated geno-
types may y1eld worthwhtle data on precise ways in which AY fa and 
a; a gene pr?ducts affect melan~some ontogeny and melanogenesis. 
Our quahtative and quantitative data based on morphologic ana ly-
ses of melanosome .ontogeny may best be described as supporting 
the 1dea that MSJ:I mduces In A r /a melanocytes a partial or incom-
plete transformation from phaeo- to eumelanogenesis. N ot one of 
the 1841 MSH-treated AY /a melanosomes possessed a classical a/ a 
matrix complete with lo.ngitudinal ly arran ged parallel fil amentous 
complexes showmg typical eumelanosome cross-linking. A small 
percentage of MSH-treated AY /a melanosomes possessed mosaic 
matnces. In general, these mosaics may be described as having matri-
ces that are hyb:ids between the fundamental phaeomelanogenesis 
plan (amplificatiOn and coalescence of vesiculoglobular bodies (1 7]) 
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Figure 3. Geometric data (means± SEM, A-D) and semiquantitative scores {E, F) of melanosomes of MSH-trea ted Ay/a {opm bars) and a/a (solid bars) 
regenerating hairbulb melanocytes. A, length vs developmental stage; B, width versus developmental stage; C, length-to-width ratio versus developmental 
stage; D, area versus developmental stage; E, matrix score frequency; F, Vesiculoglobular body score frequency. 
and the fundamental eumelanogenesis plan (amplification and lat-
tice- like organization of filamentous elements [21 ]). Some mosaic 
melanosomes possessed longitudinally disposed thickened melano-
fi laments along which vesiculoglobular-like bodies were aligned in 
a linear manner (Fig 2D, E, G,) . Experiments conducted by Tamate 
and Takeuchi [23,24) also showed that MSH-treated AY /a melano-
cytes contained mosaic melanosomes consisting of eu- and phaeo-
melanic components. 
The absence of rypical eumelanosome-like matrices in our MSH-
treated AY /a melanosomes, observed by Geschwind et al [7] , may be 
due to two factors, i.e., specific MSH treatment protocol and age of 
mice. We injected previously plucked adul t mice, (60-80 days of 
age), on days 4-8 of their hair regeneration cycle with 25.0 Jlg 
a-MSH/100 )11 PBS (0.15 mM MSH). In contrast, Geschwind et a] 
(7] injected MSH (150.0 Jlg/50 )11 of beeswax-peanut oil, 1.8 mM 
MSH) into neonatal mice (3- 6-day-old mice) as either a single or 
three individual injections during the 24-h period preceding sacri· 
lice. Both the unique endocrinologic status of neonate vs adult mice 
and the a-MSH treatment protocol could contribute to the different 
morphologic patterns in MSH-treated AY /a melanosome ontogeny. 
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Table II. Effect of the Lethal Yellow All ele (AY) on Melanosomal Matrix and Number of 40 nm Vesiculoglobular Bodies Within 
Melanosomes Fol lowing MSH Treatment 
Genotype 
a/a 
AY/a 
25.4(178)' 
45.9(493) 
Matrix Scores•,J 
2 
14.2(100) 
9.3(100) 
3 
4.8(34) 
17.9(192) 
4 
55.6(390) 
27.0(290) 
47.2(331) 
44.0(473) 
Vesiculoglobular Body Scoresb,J 
2 
27. 1(1 90) 
14.1 (152) 
3 
25 .7(180) 
41.9(450) 
.. Matrix score was based o n presence and organizatio n of filamentous matrix componen ts. Matrices contained no compo nents (1 ), uno rgan ized components (2), unorganized and 
organized components (3), or organized components only (4). . . . . . 
b Vcsicu loglobular body (VG) score was based on the number of 40-nm vesicles contamed W1ri11n melanosomes. Mclanosomes possessed no VG bodiCs (1), 1 -3 VG bodies (2), or 
greater chan 3 VG bodies (3). 
'Frequency in percent (number of observations). . 
J Based on X' comparisons of all data , ge noty pes were significa ntl y different (p < 0.05) with respect to both matnx scores and VG scores. 
To verify that mouse age is a critical factor with respect to MSH 
response, hairbulb melanocytes of C3H-He AvrjAvy mice are re-
sponsive to MSH at puberty but refractory to MSH as adu lts [1 3]. 
Quantitative data presented in this study show that MSH did not 
completely transform or "eumelanize" Ar /a melanosomes. Table I, 
row 5 provides quantitative data on melanosome geometry not sub-
ject to staging bias; all parameters except length-to-width ratios 
were statistically different between genotypes. Similarly, quantita-
tive data on melanosomal matrix condition and number of 40-nm 
vesiculoglobular bodies per melanosome (Table II) confirm that 
MSH-treated melanocytes fail ed to undergo a complete yellow-to-
black transformation and maintained features of their unique geneti-
cally yel low (Ar /a) identity. Data of Jimbow and coworkers on 
number of vesiculoglobular bodies per melanosome show that un-
treated Ar /a and a/a Stage II melanosomes possess a mean of 15.2 
and 4.3 vesiculoglobular bodies, respectively [16) (Table II). Our 
vesiculoglobular body data also show that VG bodies were statisti-
cally more numerous in MSH-treated Ar /a vs a/a melanosomes. 
Length/width ratios of Stage II and III melanosomes indicate a 
greater degree of plasticity of shape change in MSH-treated a/a than 
Ay ja mice. In a previous analysis of melanosome differentiation in 
untreated neonatal hairbulb melanocytes [22], melanosomes of a/a 
were also decidedly more plastic in their abi iity to change shape 
than those of Ay /a; length/ width ratios of a/a developmenta l stages 
I-IV were 1.5, 1.5, 1.8 , and 1.5, respectively, whereas those of 
Ay ja were 1.3, 1.3, 1.4, and 1.3, respectively. Although these quan-
titative data are subj ect to the limitations of quantitative electron 
microscopy discussed above, we believe the care, precision, number 
of melanosomes sa mpled, and other fea tures of the present design 
provide confidence that these data refl ect true biologic events of 
melanosome differentiation. Accordingly, shapes of differentiating 
a/a melanosomes are more plas tic than those of Ay ja. One interpre-
tation for this differentia l pl asticity between genotypes is the ability 
of a/a melanosomes to produce an organized, three-dimensional, 
longitudina lly disposed matrix. Polymerization of this matrix may 
faci litate the rapid spherical to elliptica l shape change occurring in 
Stage II and III a/a melanosomes. In contrast to a previous control 
srudy in which the dramatic change of a/a melanosomes occurred 
during Stage III [22], MSH-treated a/a melanosomes underwent 
shape changes at Stage II. This latter observation suggests that exog-
enous MSH can speed up the process of melanosome shape change 
in a/a mice. As they mature, elliptical Stage II and III a/a melano-
somes return to a more spherical Stage IV shape, possibly because of 
uniform eumelanin deposition. Because Ay /a mice are incapable of 
producing an organized melanosomal matrix [22], they fail to un-
dergo dramatic fluctu ations in shape durin g their maturation. 
Melanosomes ofMSH-treated Ar /a mice were more elliptical and 
2-3 times small er than untreated controls [7]. Upon comparing 
present data on a-MSH-treated Ar /a melanosome geometry to 
those of Granho lm et al ([22) T able 5) , MSH did promote a sma ller 
size as well as a more elliptica l shape in A r /a melanosomes. Al-
though comparisons between neonatal data [22] of Table I, row 6 to 
regenerating hairbulb data of adults (Table I, rows 1-5) may not be 
entirely valid because of the age difference, MSH-treated Ar ja 
melanosomes may be sli ghtly more elliptical and considerabl y 
smaller than untreated Ar /a melanosomes. Thus, MSH may affect 
the overall size as well as shape and matrix in Ar /a hairbulb mel a no-
somes. 
In addition to ultrastructural changes, a-MSH also influences 
certain enzyme activities (TH, DO, and DCOR) and type of mela-
nin produced in Ay /a melanocytes. Both tyrosinases (TH and DO) 
and dopachrome oxidoreductase (DCOR) show increases in activity 
fo llowing exogenous MSH treatments [9, 11 - 13]. Lamoreux et al 
([11] Fig 9) show resto~ation of DO activity in MSH-treated Ar /a 
melanocytes nearly eqlllvalent to that of a/a controls. With respect 
to an MSH-induced switch in the production of phaeo- to eumel-
anin, Burchill et al (13] reported no increases in eumelanin or TH 
activity in regenerating hairbulbs of phaeomelanin-producing adult 
Avr homozygotes. In contrast, MSH-treated A rja melanocytes in-
creased the production of eumelanin and phaeomelanin by 300% 
and 160%, respectively , over that of untreated Arja controls [10] . 
These enzyme and pigment data support the notion that MSH or 
MSH-like compounds are normal in vivo regulators of the agouti 
switch; gene products encoded by Ar and produced within Ay/a 
follicul ar cell s may compete with MSH for sites on MSH receptors 
of hairbu lb melanocytes [24,25). The use of specifica lly synthesized 
melanotropin analogues [26] coup! ed with quantitative electronmi-
croscopy of melanosome transformation in Ar /a mice could provide 
data on minimum peptide requirements needed to "throw the 
agouti switch." . 
In summary, a-MSH induces a striking visual darkenin g by pro-
moting a transformatiOn from phaeo- to eumelanogenesis in hair-
bulb melanocytes of mice [7 ,9, 11, 13,23]. In this study, statistically 
significant differences occurred between a-MSH- treated geno-
types in every variable under invest igation ; these data suggest that 
a-MSH did not induce a complete transformation of phaeo- to 
eumelanogenesis in Ar /a hairbulb melanocytes. Under the influ-
ence of exogenous MSH, regenerating adult Ar /a hairbulb melano-
cytes synthesize eumelanin within melanosomes that are mosaics in 
terms of their overall geom etry (length , width, shape, area) and 
internal matrix. _The contmued investi gation of the dynamics of 
melanm synthesiS 111 MSH-mduced hairbu lb melanocytes of mice 
possessmg mosaic matnces may be productive in understanding 
fundamental_ regulatory rel atwns l~Ips between tyrosinase activiry, 
matnx function, matnx orgamzatwn, and melanin (phaeo- and/or 
eumelanin) sy nthesis. 
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